The Role of Ghrelin/GHS-R1A Signaling in Nonalcohol Drug Addictions
Open accessThe DOI matches its Crossref record; 234 of the 234 references it cites were found in a registry or an index.
Abstract
Drug addiction causes constant serious health, social, and economic burden within the human society. The current drug dependence pharmacotherapies, particularly relapse prevention, remain limited, unsatisfactory, unreliable for opioids and tobacco, and even symptomatic for stimulants and cannabinoids, thus, new more effective treatment strategies are researched. The antagonism of the growth hormone secretagogue receptor type A (GHS-R1A) has been recently proposed as a novel alcohol addiction treatment strategy, and it has been intensively studied in experimental models of other addictive drugs, such as nicotine, stimulants, opioids and cannabinoids. The role of ghrelin signaling in these drugs effects has also been investigated. The present review aims to provide a comprehensive overview of preclinical and clinical studies focused on ghrelin’s/GHS-R1A possible involvement in these nonalcohol addictive drugs reinforcing effects and addiction. Although the investigation is still in its early stage, majority of the existing reviewed experimental results from rodents with the addition of few human studies, that searched correlations between the genetic variations of the ghrelin signaling or the ghrelin blood content with the addictive drugs effects, have indicated the importance of the ghrelin’s/GHS-R1As involvement in the nonalcohol abused drugs pro-addictive effects. Further research is necessary to elucidate the exact involved mechanisms and to verify the future potential utilization and safety of the GHS-R1A antagonism use for these drug addiction therapies, particularly for reducing the risk of relapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Preclinical studies suggest that ghrelin/GHS-R1a has a significant role in the reinforcing effects of opioids, and in preclinical addiction studies, GHS-R1a antagonism decreased the opioid reward and the symptoms of craving for opioids (139).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–234 of 234
Havlickova, T., Charalambous, C., Lapka, M., Puskina, N., Jerabek, P., & Šustková-Fišerová, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102925 · Cited by 31
Self-citationYou, Z.-B., Wang, B., Gardner, E. L., & Wise, R. A. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.11.001 · Cited by 31
Šustková-Fišerová, M., Charalambous, C., Havlickova, T., Lapka, M., Jerabek, P., Puskina, N., & Syslová, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112486 · Cited by 28
Self-citationRole of mesolimbic ghrelin in the acquisition of cocaine reward
Dunn, D. P., Bastacky, J. M. R., Gray, C. C., Abtahi, S., & Currie, P. J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134367 · Cited by 28
You, Z., Galaj, E., Alén, F., Wang, B., Bi, G., Moore, A. R., Buck, T. G., Crissman, M. E., Pari, S., Xi, Z., et al. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01249-2 · Cited by 28
Changes of ghrelin and leptin levels in plasma by cigarette smoke in rats
Tomoda, K., Kubo, K., Nishii, Y., Yamamoto, Y., Yoshikawa, M., & Kimura, H. (2012) · The Journal of Toxicological Sciences · doi:10.2131/jts.37.131 · Cited by 27
Ghrelin and Nicotine Stimulate Equally the Dopamine Release in the Rat Amygdala
Palotai, M., Bagosi, Z., Jászberényi, M., Csabafi, K., Dochnal, R., Manczinger, M., Telegdy, G., & Szabó, G. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1105-1 · Cited by 27
Higher fasting ghrelin serum levels in active smokers than in former and never-smokers
Wittekind, D. A., Kratzsch, J., Mergl, R., Enzenbach, C., Witte, A. V., Villringer, A., & Kluge, M. (2019) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1671610 · Cited by 27
Lee, M. R., Farokhnia, M., Cobbina, E., Saravanakumar, A., Li, X., Battista, J. T., Farinelli, L. A., Akhlaghi, F., & Leggio, L. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107788 · Cited by 27 · cited 6×
“Even though the 14 days use of the GHS-R1A inverse agonist in alcohol-addicted patients did not require discontinuation due to adverse reactions [97], the complexity of central and peripheral ghrelin’s physiological roles [38] implies possible prospective unwanted consequences of (prolonged) GHS-R1A-blocking therapy.”
BackgroundMethodInfluentialD’Cunha, T. M., Chisholm, A., Hryhorczuk, C., Fulton, S., & Shalev, U. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05415-9 · Cited by 27
Genetic Variation of the Ghrelin Signalling System in Individuals with Amphetamine Dependence
Suchankova, P., Jerlhag, E., Jayaram‐Lindström, N., Nilsson, S., Torén, K., Rosengren, A., Engel, J. A., & Franck, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061242 · Cited by 26
Changes in circulating peptide YY and ghrelin are associated with early smoking relapse
Lemieux, A. M., & Al’Absi, M. (2017) · Biological Psychology · doi:10.1016/j.biopsycho.2017.03.007 · Cited by 26
Alcohol-Related Mortality in the WHO European Region: Sex-Specific Trends and Predictions
Pruckner, N., Hinterbuchinger, B., Fellinger, M., König, D., Waldhoer, T., Lesch, O., Gmeiner, A., Vyssoki, S., & Vyssoki, B. (2019) · Alcohol and Alcoholism · doi:10.1093/alcalc/agz063 · Cited by 26 · cited 1×
“5 % of all annual deaths in Europe are alcohol-attributable and ~16% of all deaths in adults over 30 are tobacco-related, with many of these deaths occurring prematurely [1,2].”
BackgroundThe effect of hydroalcoholic extract of Cannabis Sativa on appetite hormone in rat
Mazidi, M., Taraghdari, S. B., Rezaee, P., Kamgar, M., Jomezadeh, M. R., Hasani, O. A., Soukhtanloo, M., Hosseini, M., Gholamnezhad, Z., Rakhshandeh, H., et al. (2014) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2014-0006 · Cited by 25
Ribeiro, L. F., Catarino, T., de Carvalho, M. L., Cortes, L., Santos, S. D., Opazo, P., Ribeiro, L. R., Oliveiros, B., Choquet, D., Esteban, J. A., et al. (2021) · Science Signaling · doi:10.1126/scisignal.abb1953 · Cited by 25
Nicotine administration in healthy non-smokers reduces appetite but does not alter plasma ghrelin
Pilhatsch, M., Scheuing, H., Kroemer, N. B., Kobiella, A., Bidlingmaier, M., Farger, G., Smolka, M. N., & Zimmermann, U. S. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2405 · Cited by 24
Ghrelin Receptor Influence on Cocaine Reward is Not Directly Dependent on Peripheral Acyl-Ghrelin
Wenthur, C. J., Gautam, R., Zhou, B., Vendruscolo, L. F., Leggio, L., & Janda, K. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-38549-z · Cited by 24 · cited 2×
“These results indicate that the central GHS-R1As that regulate weight-gain behavior are physiologically dependent on peripheral acyl-ghrelin activation, whereas hedonic reward due to cocaine administration does not appear to require peripheral acyl-ghrelin [54].”
BackgroundExpression of the growth hormone secretagogue receptor 1a (GHS‐R1a) in the brain
Airapetov, M. I., Eresko, S. O., Aa, L., Бычков, Э. Р., & Shabanov, P. D. (2021) · Physiological Reports · doi:10.14814/phy2.15113 · Cited by 24 · cited 1×
“The GHS-R1A is metabotropic and uses several different G-protein secondary-messenger signaling pathways [66,67].”
BackgroundGhrelin precursor gene polymorphism and methamphetamine dependence in the Korean population
Yoon, S. J., Pae, C., Lee, H., Choi, B., Kim, T. S., Lyoo, I. K., Kwon, D.-H., & Kim, D. (2005) · Neuroscience Research · doi:10.1016/j.neures.2005.08.013 · Cited by 22
Charalambous, C., Lapka, M., Havlickova, T., Syslová, K., & Šustková-Fišerová, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010210 · Cited by 22
Self-citationBouhours‐Nouet, N., de Casson, F. B., Rouleau, S., Douay, O., Mathieu, E., Bouderlique, C., Gillard, P., Limal, J. M., Descamps, P., & Coutant, R. (2006) · Hormone Research in Paediatrics · doi:10.1159/000092807 · Cited by 21
Acute One-Cigarette Smoking Decreases Ghrelin Hormone in Saliva: A Pilot Study
Kaabi, Y. A., & Khalifa, M. A. A. A. (2014) · International Journal of Endocrinology · doi:10.1155/2014/575671 · Cited by 19
Charalambous, C., Havlickova, T., Lapka, M., Puskina, N., Šlamberová, R., Kuchař, M., & Šustková-Fišerová, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052397 · Cited by 19
Self-citationJang, J. K., Kim, W. Y., Cho, B. R., Lee, J. W., & Kim, J. (2017) · Addiction Biology · doi:10.1111/adb.12533 · Cited by 18
The effect of food deprivation on cigarette smoking in females
Kendzor, D. E., Baillie, L. E., Adams, C. E., Stewart, D. W., & Copeland, A. L. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.06.008 · Cited by 17
Ali, S. S., Hamed, E. A., Ayuob, N. N., Ali, A. S., & Suliman, M. I. (2015) · Experimental Physiology · doi:10.1113/ep085015 · Cited by 16
Cleverdon, E. R., McGovern-Gooch, K. R., & Hougland, J. L. (2016) · Molecular Membrane Biology · doi:10.1080/09687688.2017.1388930 · Cited by 15
The sigma-1 receptor as key common factor in cocaine and food-seeking behaviors
Aguinaga, D., Casanovas, M., Rivas‐Santisteban, R., Reyes‐Resina, I., Navarro, G., & Franco, R. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-19-0138 · Cited by 15
Al’Absi, M., DeAngelis, B. N., Nakajima, M., Hatsukami, D. K., & ALLEN, S. S. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106866 · Cited by 14
Cobbina, E., Lee, M. R., Leggio, L., & Akhlaghi, F. (2020) · Clinical Pharmacokinetics · doi:10.1007/s40262-020-00942-7 · Cited by 13 · cited 4×
“The update of the clinical study using PF5190457 was mentioned above [71,97,98].”
BackgroundMethodInfluentialProtective effects of ghrelin on brain mitochondria after cardiac arrest and resuscitation
Xu, H., Li, Y., Liu, R., Wu, L., Zhang, C., Ding, N., Ma, A., Zhang, J., & Xie, X. (2019) · Neuropeptides · doi:10.1016/j.npep.2019.05.007 · Cited by 12
Zhao, J., Du, X., Chen, M., & Zhu, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.718615 · Cited by 10
Kara, H., Erdogan, A. R., Akbas, H. S., & Kuloğlu, M. M. (2021) · ALPHA PSYCHIATRY · doi:10.5152/alphapsychiatry.2021.2056 · Cited by 3
[From nicotine dependence to addictology].
Aubin, H., Luquiens, A., Bonnet, N., & Borgne, A. (2012) · PubMed · Cited by 1
Cited by
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 39
“Cont.”
Etxandi, M., Baenas, I., Mora‐Maltas, B., Granero, R., Fernández‐Aranda, F., Tovar, S. A., Solé‐Morata, N., Lucas, I., Casado, S., Gómez‐Peña, M., et al. (2022) · Nutrients · doi:10.3390/nu14235084 · Cited by 16
“Noticeably, ghrelin up-regulation has been described in SUDs, which positively correlates with craving, abstinence, and relapse [17–19].”
BackgroundInfluentialExogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Tunagur, E. M. K., Yazıcı, A. B., Güzel, D., Tunagür, M. T., Ermiş, Ç., Suda, M. A., & Yazıcı, E. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109577 · Cited by 9
Orellana, E. R., Horvath, N., Farokhnia, M., Leggio, L., & Hajnal, A. S. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.019 · Cited by 9
Metadata
- Authors
- Sustkova-Fiserova, M., Charalambous, C., Khryakova, A., Certilina, A., Lapka, M., & Šlamberová, R.
- Affiliations
- Department of Pharmacology, Third Faculty of Medicine, Charles University, Ruska 87, 100 00 Prague, Czech Republic
- Charles University (CZ)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-11
- Volume
- 23
- Issue
- 2
- Pages
- 761
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8776007
- OpenAlex
- W4206420944
- Semantic Scholar
- aa8b6baae25d8dd94aa269e1d610480af54eb54f
- Cited by
- 12
- References
- 234
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 2 · 2023: 4 · 2022: 3
- FWCI
- 0.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Univerzita Karlova v Praze (260533/SVV/2021, PROGRES Q35)
- Grantová Agentura České Republiky (GA21-30795S)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- ghrelin, GHS-R1a, growth hormone secretagogue receptor, drug addiction, nicotine dependence, opioid use disorder, stimulant use disorder, relapse prevention, addiction pharmacotherapy, genetic variation
- MeSH terms
- Clinical Studies as Topic, Central Nervous System Stimulants, Animals, Disease Models, Animal, Disease Susceptibility, Humans, Nicotine, Reinforcement, Psychology, Signal Transduction, Biomarkers, Substance-Related Disorders, Genetic Predisposition to Disease, Ghrelin, Receptors, Ghrelin, Tobacco Use
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.